Tag Archives: puberty blockers

Four recent studies confirm benefits of medical transition for trans adolescents

Puberty-blocking medications are used in gender-dysphoric adolescents as a means of temporarily and reversibly inhibiting an undesired natal puberty. In the event that their dysphoria desists, the medication can be discontinued, and their natal puberty will resume; if their dysphoria … Continue reading

Posted in Endocrinology, Gender dysphoria, Outcomes of transition, Trans youth | Tagged , , , , | 1 Comment

Why gender-questioning youth continue or discontinue puberty blockers

Puberty-blocking medications for trans or gender-questioning adolescents, which reversibly halt the production of sex hormones and prevent the development of undesired secondary sex characteristics for as long as the medication is continued, have long been the subject of unnecessary controversy … Continue reading

Posted in Nonbinary, Outcomes of transition, Regret and detransition, Trans youth | Tagged , , | Leave a comment

Puberty blockers can be beneficial for trans girls even in late adolescence

Guidelines for the treatment of trans adolescents with puberty blockers and cross-sex hormones recommend that puberty blockers should be initiated once the first physical changes of natal puberty, Tanner stage 2, have begun (Hembree et al., 2017). However, in practice, … Continue reading

Posted in Endocrinology, Trans youth | Tagged , | Leave a comment

Use of puberty blockers in transgender girls, effects on genital tissue development, and vaginoplasty options

Background and description of the issue GnRH analogue medications such as Lupron, Decapeptyl, and Supprelin LA have been in use since the early 1990s to halt natal pubertal development at Tanner stage 2 or 3 in transgender adolescents with persistent … Continue reading

Posted in Endocrinology, Outcomes of transition, Surgery, Trans youth, Transgender medicine | Tagged , , , , , | Leave a comment

4thWaveNow “ROGD parent” Brie Jontry doesn’t know what histrelin is

4thWaveNow, one of the three survey respondent recruitment sites for the badly flawed study of an alleged new “rapid onset gender dysphoria” condition, has long served as a clearinghouse for questionable notions about puberty-blocking medications used for transgender youth. These … Continue reading

Posted in Endocrinology, Health care, Trans youth, Transgender medicine | Tagged , , , , , , , | Leave a comment